跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,355 条关于
“Repligen Corp”
全部
6,355
临床试验
4,947
药物
450
机构
370
资讯
588
2个月前
Repligen to Acquire BioLife Solutions in $1.5 Billion Deal, Expanding into Cell Therapy Market
上个月
Global Bioprocessing Equipment Market to Reach $152.2 Billion by 2035, Driven by Biologics Boom and Single-Use Technology Adoption
3个月前
Continuous Bioprocessing Market Projected to Reach $1.64 Billion by 2034, Driven by Biologics Manufacturing Demand
上个月
mRNA Synthesis Raw Materials Market to Surpass USD 3.89 Billion by 2035
28天前
Azenta Appoints Dr. Martin Madaus as Interim CEO Amid Leadership Transition
3个月前
Preparative and Process Chromatography Market Projected to Reach $29.53 Billion by 2035, Driven by Biologics Manufacturing Boom
去年
Yokogawa and Repligen Partner to Advance Real-Time Bioprocess Monitoring Technology
去年
BriaCell Therapeutics Reports Progress in Phase 3 Metastatic Breast Cancer Trial
去年
BriaCell's Bria-IMT™ Shows Promise in Metastatic Breast Cancer Phase 2 Trial
去年
Scholar Rock's Apitegromab Shows Promise in SMA, Faces Financial and Development Hurdles
第 1 页,共 59 页
上一页
下一页